Que has received the most research attention on antioxidant therapy for AMD, which can be divided into three main aspects: clearing ROS, regulating nuclear factor erythroid 2-related factor 2 (NRF2) and secondary enzymes, and inhibiting phototoxicity (Figure 2). The gene discussed is NFE2L2; the disease is age-related macular degeneration.